Chemical Compound

SB-1518|||(16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene

CAS Registry Number 937272-79-2
SB-1518|||(16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene 结构式
Primary record

SB-1518|||(16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene

库存
9,571 克
纯度
99.3 %
CAS
937272-79-2

化合物标识与属性

CAS
937272-79-2
PubChem CID
46216796
SMILES
C1CCN(C1)CCOC2=C3COC/C=C/COCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2
Canonical SMILES
C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1

名称与同义词

  • Pacritinib
  • Pacritinib (SB1518)
  • pacritinibum
  • 937272-79-2
  • Vonjo
  • SB1518
  • PEDttHD
  • Pacritinib [INN]
  • Pacritinib(SB1518)
  • Vonjo (TN)
  • Pacritinib (Standard)
  • SB-1518
  • SB1518(Pacritinib)
  • RefChem:58092
  • Pacritinib (USAN/INN)
  • Pacritinib [USAN:INN]
  • G22N65IL3O
  • PACRITINIB [USAN]
  • ONX-0803
  • PACRITINIB [WHO-DD]
  • SB-1518 TFA salt
  • UNII-G22N65IL3O
  • MFCD22572772
  • SB 1518
  • C28H32N4O3
  • DTXSID801045679
  • GTPL7793
  • orb1301145
  • CHEMBL2035187
  • CHEMBL2181330
  • Oral JAK2 Inhibitor SB1518
  • SCHEMBL22819303
  • SCHEMBL29358663
  • SCHEMBL29617552
  • EX-A240
  • CHEBI:231350
  • DTXCID201527601
  • GLXC-90080
  • AMY23364
  • AOB87797
  • BAX 2201
  • BCP09091
  • MMB27279
  • ONX 0803
  • 2626AH
  • ABP001102
  • ARD193602
  • BDBM50210177
  • BDBM50400312
  • HY-16379R
  • NSC759674
  • NSC781626
  • s8057
  • AKOS037515687
  • ACN-025761
  • CCG-269464
  • CS-1741
  • DB11697
  • NSC-759674
  • NSC-781626
  • NCGC00381564-02
  • NCGC00381564-08
  • NCGC00381564-09
  • NCGC00390623-02
  • AC-30280
  • AS-35036
  • HY-16379
  • FT-0701734
  • SW219864-1
  • J3.548.848K
  • A12694
  • D11768
  • SB1518;SB-1518;SB 1518
  • Z-3133
  • A856343
  • (16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-Dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene
  • 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
  • Q3888693
  • BRD-K19034817-001-01-4
  • BRD-K19034817-001-02-2
  • BRD-K19034817-001-04-8
  • B0084-462754
  • (16E)-11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(24),2(27),3,5,8(26),9,11,16,21(25),22-decaene
  • 14,19-Dioxa-5,7,27-triazatetracyclo(19.3.1.12,6.18,12)heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 11-(2-(1-pyrrolidinyl)ethoxy)-, (16E)-
  • (16E)-11-(2-(pyrrolidin-1-yl)ethoxy)-14,19-dioxa-5,7,27-triazatetracyclo(19.3.1.1^(2,6).1^(8,12))heptacosa-1(25),2(27),3,5,8,10,12(26),16,21,23-decaene
  • (16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8(26),9,11,16,21,23-decaene
  • (16E)-11-[2-(pyrrolidin-1-yl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(27),3,5,8(26),9,11,16,21,23-decaene
  • 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
  • 11-[2-(pyrrolidin-1-yl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(24),2(27),3,5,8,10,12(26),16,21(25),22-decaene
  • 11-[2-(Pyrrolidine-1-yl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosane-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene
  • 2197126-32-0
  • 6T3
  • SB 1518; (E)-44-(2-(pyrrolidin-1-yl)ethoxy)-6,11-dioxa-3-aza-2(4,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-ene
  • SB-1518|||(16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene